HEATHER CHEANEY: Open Payments
NPI 1225487143 · FARMINGTON, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$269 in 6 payments from 6 companies in 2025. Trend: 2023 $993 · 2024 $660 · 2025 $269
Food & beverage: $269
| Company | Payments | Amount |
|---|---|---|
| Optinose US, Inc. | 1 | $122 |
| Smith+Nephew, Inc. | 1 | $59 |
| GlaxoSmithKline, LLC. | 1 | $29 |
| GENZYME CORPORATION | 1 | $25 |
| Viatris Specialty LLC | 1 | $18 |
| UCB, Inc. | 1 | $17 |
Products named: Xhance, TULA, NUCALA, DUPIXENT, YUPELRI, Bimzelx.
Industry payments across MO — which companies pay providers there.
